Royal Australian and New Zealand College of Psychiatrists Professional Practice Guidelines for the Administration of Repetitive Transcranial Magnetic Stimulation

Overview

Journal Aust N Z J Psychiatry

Specialty Psychiatry

Date 2024 May 6

PMID 38706202

Authors

Salam Hussain

Suneel Chamoli

Paul FitzGerald

Ashu Gandhi

Shane Gill

Shanthi Sarma

Colleen Loo

Affiliations

Soon will be listed here.

Abstract

Objectives: To provide guidance for the optimal administration of repetitive transcranial magnetic stimulation, based on scientific evidence and supplemented by expert clinical consensus.

Methods: Articles and information were sourced from existing guidelines and published literature. The findings were then formulated into consensus-based recommendations and guidance by the authors. The guidelines were subjected to rigorous successive consultation within the RANZCP, involving the Section of ECT and Neurostimulation (SEN) Committee, its broader membership and expert committees.

Results: The RANZCP professional practice guidelines (PPG) for the administration of rTMS provide up-to-date advice regarding the use of rTMS in clinical practice. The guidelines are intended for use by psychiatrists and non-psychiatrists engaged in the administration of rTMS to facilitate best practice to optimise outcomes for patients. The guidelines strive to find the appropriate balance between promoting best evidence-based practice and acknowledging that evidence for rTMS use is a continually evolving.

Conclusion: The guidelines provide up-to-date advice for psychiatrists and non-psychiatrists to promote optimal standards of rTMS practice.

Citing Articles

Is It Possible to Combine Non-Invasive Brain Stimulation and Evidence-Based Psychosocial Interventions in Schizophrenia? A Critical Review.

Lisoni J, Nibbio G, Baglioni A, Dini S, Manera B, Maccari A Brain Sci. 2024; 14(11).

PMID: 39595830 PMC: 11591595. DOI: 10.3390/brainsci14111067.

References

Fitzgerald P . Is Maintenance Repetitive Transcranial Magnetic Stimulation for Patients With Depression a Valid Therapeutic Strategy?. Clin Pharmacol Ther. 2019; 106(4):723-725. DOI: 10.1002/cpt.1566. View

Hendriks L, Mihalopoulos C, Le L, Loo C, Chatterton M . Cost-utility analysis of rTMS as add-on therapy to standard care for the treatment of hallucinations in schizophrenia. Eur Psychiatry. 2022; :1-32. PMC: 9058442. DOI: 10.1192/j.eurpsy.2022.13. View

Brunoni A, Chaimani A, Moffa A, Razza L, Gattaz W, Daskalakis Z . Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis. JAMA Psychiatry. 2016; 74(2):143-152. DOI: 10.1001/jamapsychiatry.2016.3644. View

Hoffman R, Hawkins K, Gueorguieva R, Boutros N, Rachid F, Carroll K . Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry. 2003; 60(1):49-56. DOI: 10.1001/archpsyc.60.1.49. View

George M, Lisanby S, Avery D, McDonald W, Durkalski V, Pavlicova M . Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010; 67(5):507-16. DOI: 10.1001/archgenpsychiatry.2010.46. View

Shao D, Zhao Z, Zhang Y, Zhou X, Zhao L, Dong M . Efficacy of repetitive transcranial magnetic stimulation for post-stroke depression: a systematic review and meta-analysis of randomized clinical trials. Braz J Med Biol Res. 2021; 54(3):e10010. PMC: 7812912. DOI: 10.1590/1414-431X202010010. View

Gregory S, Goodman W, Kay B, Riemann B, Storch E . Cost-effectiveness analysis of deep transcranial magnetic stimulation relative to evidence-based strategies for treatment-refractory obsessive-compulsive disorder. J Psychiatr Res. 2021; 146:50-54. DOI: 10.1016/j.jpsychires.2021.12.034. View

Zhou D, Wang W, Wang G, Li D, Kuang L . An updated meta-analysis: Short-term therapeutic effects of repeated transcranial magnetic stimulation in treating obsessive-compulsive disorder. J Affect Disord. 2017; 215:187-196. DOI: 10.1016/j.jad.2017.03.033. View

Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E . Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016; 50(5):410-72. DOI: 10.1177/0004867416641195. View

10.

Johnstone S, Sorkhou M, Al-Saghir N, Lowe D, Steele V, Pearlson G . Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review. Front Psychiatry. 2022; 13:793938. PMC: 8882683. DOI: 10.3389/fpsyt.2022.793938. View

11.

Caulfield K, Fleischmann H, George M, McTeague L . Reply to "Letter to the editor: Safety of "accelerated" rTMS protocols with twice-daily sessions in patients with schizophrenia - A comment on Caulfield et al.". J Psychiatr Res. 2022; 156:758-760. DOI: 10.1016/j.jpsychires.2022.08.021. View

12.

Fitzgerald P . Targeting repetitive transcranial magnetic stimulation in depression: do we really know what we are stimulating and how best to do it?. Brain Stimul. 2021; 14(3):730-736. DOI: 10.1016/j.brs.2021.04.018. View

13.

OReardon J, Solvason H, Janicak P, Sampson S, Isenberg K, Nahas Z . Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007; 62(11):1208-16. DOI: 10.1016/j.biopsych.2007.01.018. View

14.

Zis P, Shafique F, Hadjivassiliou M, Blackburn D, Venneri A, Iliodromiti S . Safety, Tolerability, and Nocebo Phenomena During Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis of Placebo-Controlled Clinical Trials. Neuromodulation. 2019; 23(3):291-300. DOI: 10.1111/ner.12946. View

15.

Lorentzen R, Nguyen T, McGirr A, Hieronymus F, Ostergaard S . The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis. Schizophrenia (Heidelb). 2022; 8(1):35. PMC: 9261093. DOI: 10.1038/s41537-022-00248-6. View

16.

Sackeim H, Aaronson S, Carpenter L, Hutton T, Mina M, Pages K . Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation. J Affect Disord. 2020; 277:65-74. DOI: 10.1016/j.jad.2020.08.005. View

17.

Demirtas-Tatlidede A, Mechanic-Hamilton D, Press D, Pearlman C, Stern W, Thall M . An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients. J Clin Psychiatry. 2008; 69(6):930-4. DOI: 10.4088/jcp.v69n0607. View

18.

Slotema C, Blom J, van Lutterveld R, Hoek H, Sommer I . Review of the efficacy of transcranial magnetic stimulation for auditory verbal hallucinations. Biol Psychiatry. 2013; 76(2):101-10. DOI: 10.1016/j.biopsych.2013.09.038. View

19.

Papadimitropoulou K, Vossen C, Karabis A, Donatti C, Kubitz N . Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis. Curr Med Res Opin. 2016; 33(4):701-711. DOI: 10.1080/03007995.2016.1277201. View

20.

Gay A, Cabe J, De Chazeron I, Lambert C, Defour M, Bhoowabul V . Repetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis. J Clin Med. 2022; 11(3). PMC: 8836499. DOI: 10.3390/jcm11030624. View